Carl Adams
Comptroller/Controller/Auditor en TELEDYNE TECHNOLOGIES INCORPORATED .
Perfil
Carl Adams is currently the Chief Audit Executive & Vice President at Teledyne Technologies, Inc. He previously worked as the Chief Financial Officer & Vice President at NeuroSigma, Inc. in 2014.
He completed his undergraduate degree at California State University-Northridge.
Cargos activos de Carl Adams
| Empresas | Cargo | Inicio |
|---|---|---|
| TELEDYNE TECHNOLOGIES INCORPORATED | Comptroller/Controller/Auditor | 01/12/2023 |
Antiguos cargos conocidos de Carl Adams.
| Empresas | Cargo | Fin |
|---|---|---|
NeuroSigma, Inc.
 NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Director of Finance/CFO | - |
Formación de Carl Adams.
| California State University-Northridge | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TELEDYNE TECHNOLOGIES INCORPORATED | Electronic Technology |
| Empresas privadas | 1 |
|---|---|
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Carl Adams
